gsk glp-1 Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist GLP-1 Agonists: A Comprehensive Overview

Lower intake, combined with individual dietary patterns and preexisting deficiencies, may increase the risk of insufficient intake of nutrients such as vitamin D, B vitamins, and other micronutrients

This collaborative approach can provide the best of both worlds: specialized GLP-1 expertise from your telehealth provider and thorough primary care from your local physician

for using GLP-1 in PAH management that will open the door for future study [on if] these data are reproducible in trials, Alawad said.

Central mechanisms by which peripheral GLP-1RAs may reduce appetite or induce nausea

Knowing how to talk to your doctor about GLP-1 options can make a significant difference in accessing these treatments